BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10708958)

  • 1. TGF-betas and TGF-beta receptors in atherosclerosis.
    McCaffrey TA
    Cytokine Growth Factor Rev; 2000; 11(1-2):103-14. PubMed ID: 10708958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.
    McCaffrey TA; Consigli S; Du B; Falcone DJ; Sanborn TA; Spokojny AM; Bush HL
    J Clin Invest; 1995 Dec; 96(6):2667-75. PubMed ID: 8675633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance.
    McCaffrey TA; Du B; Fu C; Bray PJ; Sanborn TA; Deutsch E; Tarazona N; Shaknovitch A; Newman G; Patterson C; Bush HL
    J Mol Cell Cardiol; 1999 Sep; 31(9):1627-42. PubMed ID: 10471347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors.
    Gebken J; Feydt A; Brinckmann J; Notbohm H; Müller PK; Bätge B
    J Endocrinol; 1999 Jun; 161(3):503-10. PubMed ID: 10334821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development.
    Bobik A; Agrotis A; Kanellakis P; Dilley R; Krushinsky A; Smirnov V; Tararak E; Condron M; Kostolias G
    Circulation; 1999 Jun; 99(22):2883-91. PubMed ID: 10359732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
    Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
    Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth.
    Smith JD; Bryant SR; Couper LL; Vary CP; Gotwals PJ; Koteliansky VE; Lindner V
    Circ Res; 1999 May; 84(10):1212-22. PubMed ID: 10347096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.
    De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.
    Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia.
    Vivien D; Bernaudin M; Buisson A; Divoux D; MacKenzie ET; Nouvelot A
    J Neurochem; 1998 Jun; 70(6):2296-304. PubMed ID: 9603194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factors beta1, beta2 and beta3 and their receptors are differentially expressed in human peritoneal fibroblasts in response to hypoxia.
    Saed GM; Collins KL; Diamond MP
    Am J Reprod Immunol; 2002 Dec; 48(6):387-93. PubMed ID: 12607775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells.
    Waiser J; Dell K; Böhler T; Dogu E; Gaedeke J; Budde K; Neumayer HH
    Nephrol Dial Transplant; 2002 Sep; 17(9):1568-77. PubMed ID: 12198207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
    Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
    Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.
    Oh SP; Seki T; Goss KA; Imamura T; Yi Y; Donahoe PK; Li L; Miyazono K; ten Dijke P; Kim S; Li E
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2626-31. PubMed ID: 10716993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol.
    Kassem M; Kveiborg M; Eriksen EF
    Eur J Clin Invest; 2000 May; 30(5):429-37. PubMed ID: 10809903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries.
    Ward MR; Sasahara T; Agrotis A; Dilley RJ; Jennings GL; Bobik A
    Atherosclerosis; 1998 Apr; 137(2):267-75. PubMed ID: 9622270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pulmonary acinar aplasia: reduction of transforming growth factor-beta ligands and receptors.
    Chen MF; Gray KD; Prentice MA; Mariano JM; Jakowlew SB
    Pediatr Res; 1999 Jul; 46(1):61-70. PubMed ID: 10400136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.